Evidence map›Paper›PMID 29752252›Full record

ArticleJMIR research protocols2018

Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study.

Svenja Litzkendorf, Tobias Hartz, Jens Göbel, Holger Storf, Frédéric Pauer, Ana Babac, Verena Lührs, Leena Bruckner-Tuderman, Franziska Schauer, Jörg Schmidtke and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Svenja LitzkendorfCenter for Health Economics Research Hannover, Department of Insurance, Leibniz University of Hanover, Hannover, Germany.ORCID http://orcid.org/0000-0003-1342-7196
Tobias HartzClinical Cancer Registry of Lower Saxony, Hannover, Germany.ORCID http://orcid.org/0000-0002-1704-0338
Jens GöbelMedical Informatics Group, University Hospital Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-8625-0841
Holger StorfMedical Informatics Group, University Hospital Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-8126-9535
Frédéric PauerCentre for Quality and Management in Healthcare, Medical Association of Lower Saxony, Hannover, Germany.ORCID http://orcid.org/0000-0003-1138-0283
Ana BabacCenter for Health Economics Research Hannover, Department of Insurance, Leibniz University of Hanover, Hannover, Germany.ORCID http://orcid.org/0000-0002-0210-5370
Verena LührsCentre for Quality and Management in Healthcare, Medical Association of Lower Saxony, Hannover, Germany.ORCID http://orcid.org/0000-0003-2153-4135
Leena Bruckner-TudermanDepartment of Dermatology, Medical University Center of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-8339-9093
Franziska SchauerDepartment of Dermatology, Medical University Center of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-5147-0123
Jörg SchmidtkeInstitute of Human Genetics, Orphanet Deutschland, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0002-6094-0120
Lisa BiehlGerman Alliance of Chronic Rare Diseases, Berlin, Germany.ORCID http://orcid.org/0000-0003-2858-5832
Tof WagnerFrankfurt Center for Rare Diseases, University Hospital Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0002-6465-4244
J-Matthias Graf von der SchulenburgCenter for Health Economics Research Hannover, Department of Insurance, Leibniz University of Hanover, Hannover, Germany.ORCID http://orcid.org/0000-0002-5322-9453
Martin FrankCentre for Quality and Management in Healthcare, Medical Association of Lower Saxony, Hannover, Germany.ORCID http://orcid.org/0000-0001-6817-6748
Goethe University Frankfurt · DELeibniz University Hannover · DEUniversity Medical Center Freiburg · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, public and political interest has focused on people living with rare diseases and their health concerns. Due to the large number of different types of rare diseases and the sizable number of patients, taking action to improve the life of those affected is gaining importance. In 2013, the federal government of Germany adopted a national action plan for rare diseases, including the call to establish a central information portal on rare diseases (Zentrales Informationsportal über seltene Erkrankungen, ZIPSE).

objectiveThe objective of this study, therefore, was to conduct scientific research on how such a portal must be designed to meet the needs of patients, their families, and medical professionals, and to provide high-quality information for information seekers.

methodsWe chose a 3-step procedure to develop a needs-based prototype of a central information portal. In the first step, we determined the information needs of patients with rare diseases, their relatives, and health care professionals by means of qualitative interviews and their content-analytical evaluation. On the basis of this, we developed the basic structure of the portal. In the second step, we identified quality criteria for websites on rare diseases to ensure that the information linked with ZIPSE meets the quality demands. Therefore, we gathered existing criteria catalogs and discussed them in an expert workshop. In the third step, we implemented and tested the developed prototypical information portal.

resultsA portal page was configured and made accessible on the Web. The structure of ZIPSE was based on the findings from 108 qualitative interviews with patients, their relatives, and health care professionals, through which numerous information needs were identified. We placed particularly important areas of information, such as symptoms, therapy, research, and advisory services, on the start page. Moreover, we defined 13 quality criteria, referring to factors such as author information, creation date, and privacy, enabling links with high-quality information. Moreover, 19 users tested all the developed routines based on usability and comprehensibility. Subsequently, we improved the visual presentation of search results and other important search functions.

conclusionsThe implemented information portal, ZIPSE, provides high-quality information on rare diseases from a central point of access. By integrating the targeted groups as well as different experts on medical information during the construction, the website can assure an improved search for information for users. ZIPSE can also serve as a model for other Web-based information systems in the field of rare diseases. REGISTERED REPORT IDENTIFIER: RR1-10.2196/7425.

Indexed as

health information exchangequalitative researchquality controlrare diseases

Identifiers

PMID29752252
PMCPMC5970281
OpenAlexW2800182929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.